Kyowa Kirin, Inc.
๐ฏ๐ตJapan
- Country
- ๐ฏ๐ตJapan
- Ownership
- -
- Established
- 1949-01-01
- Employees
- 7.1K
- Market Cap
- $12B
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Phase 3
Completed
- Conditions
- Parkinson's Disease
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin, Inc.
- Target Recruit Count
- 230
- Registration Number
- NCT00199407
- Locations
- ๐บ๐ธ
Kyowa Pharmaceutical Inc., Princeton, New Jersey, United States
An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018
Phase 3
Completed
- Conditions
- Parkinson's Disease
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin, Inc.
- Target Recruit Count
- 1100
- Registration Number
- NCT00199368
- Locations
- ๐บ๐ธ
Kyowa Pharmaceutical Inc., Princeton, New Jersey, United States
A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa
Phase 3
Completed
- Conditions
- Parkinson's Disease
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin, Inc.
- Target Recruit Count
- 580
- Registration Number
- NCT00199420
- Locations
- ๐บ๐ธ
Kyowa Pharmaceutical Inc., Princeton, New Jersey, United States
๐บ๐ธKyowa Pharmaceutical, Princeton, New Jersey, United States
A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients
Phase 2
Completed
- Conditions
- Parkinson's DiseaseMovement Disorder Syndrome
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT00199433
- Locations
- ๐บ๐ธ
Kyowa Pharmaceutical Inc., Princeton, New Jersey, United States
A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma
Phase 1
Terminated
- Conditions
- Stage IV Melanoma
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Kyowa Kirin, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT00199342
- Locations
- ๐บ๐ธ
Comprehensive Cancer Center- University of Alabama at Birmingham, Birmingham, Alabama, United States
๐บ๐ธH. Lee Moffitt Cancer Center, Tampa, Florida, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath